HMS LINCS Batch ID,HMS LINCS ID,Name,Alternative Names,LINCS ID,Alternative ID,Reference Source,Organism,Organ,Tissue,Cell Type,Details of Cell Type,Donor Sex,Donor Age,Donor Ethnicity,Donor Health Status,Disease,Details of Disease,Production Details,Genetic Modification(s),Known Mutations,Citation Information for Mutations,Verification Reference Profile,Growth Properties,Recommended Culture Conditions,Relevant Citations,Usage Note,Comments,Provider,Provider Catalog ID,Provider Batch ID,Source Information,Date Received,HMS QC Outcome,Transient Modification(s),Date Publicly Available,Most Recent Update
50149-3,50149,COLO 858,,LCL-1242,"CLO_0002569","European Collection of Authenticated Cell Cultures (ECACC) 93052613",Homo sapiens,skin,,,,male,,,,"DOID:1909, malignant melanoma",,,none,,,,adherent,"From MGH/CMT as specified by cell provider: RPMI 1640 + 2mM Glutamine + 10% Fetal Bovine Serum (FBS). Split confluent cultures 1:3 to 1:6 i.e. seeding at 2-4x10,000 cells/cm2 using 0.25% trypsin/EDTA; 37C; 5% CO2.",,,,Mohammad Fallahi-Sichani (Harvard Medical School),,,"Obtained by Mohammad Fallahi-Sichani (Harvard Medical School) from Nathan Moerke (Harvard Medical School) and distributed to Jia-Ren Lin in October, 2014. Moerke previously had obtained the cells from the Center for Molecular Therapeutics (CMT; Massachusetts General Hospital) (contact: Cyril Benes).",2012-10-29,,,2012-07-31,2016-08-24